Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001127602-23-003163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-02 | 2023-01-31 | BCRX | LEE KENNETH B JR | Dir | M - OptEx | $1.71 | +15.0K | 52.1K | +40% | +$25.6K |
| D | 2023-02-02 | 2023-01-31 | BCRX | LEE KENNETH B JR | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | M | A | 15,000 | $1.71 | 52,118 | D | — | — | |
| 2 | Derivative | Automatic Stock Option Grant | 2023-01-31 | M | D | 15,000 | $0.00 | 0 | D | $1.71 · 2013-06-30 to 2023-05-31 | 15,000 Common Stock |